CHELSEA WOOD: Open Payments
NPI 1639567118 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $307 · 2025 $936
Food & beverage: $926Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $307 |
| GENZYME CORPORATION | 6 | $168 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| LEO Pharma Inc. | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $44 |
| Lilly USA, LLC | 2 | $36 |
| UCB, Inc. | 2 | $34 |
| Amgen Inc. | 3 | $34 |
| Biocon Biologics Inc | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, ADBRY, TALTZ, Bimzelx, OTEZLA, Winlevi.
Industry payments across UT — which companies pay providers there.
